Cramer's 'Mad Money' Recap: A Monster Trade

Saks in the Bag

Cramer welcomed Saks (SKS) CEO Stephen Sadove to the show by telephone, asking the chief exec how he turned his company around.

Sadove said the retailer's turnaround is "still early in the game" but that its success has a lot to do with a "great team, clear strategies and clear focus on execution." Part of it also had to do with getting people to own equity in the company, understanding customer needs and making stores more productive, he added.

Furthermore, Sadove reassured viewers that the appointment of Saks' new CFO is absolutely normal and that Kevin Wills has been internal to the company, has a great amount of experience and is a great asset to the team.

Cramer said Coach (COH), Ralph Lauren (RL) and Saks are all companies people "can bet with."

People should take the fact that the stock has "flat-lined" as an opportunity to buy Saks, Cramer said.

To view Cramer's interview with Stephen Sadove, please click here.

During the show's "Sudden Death" round, Cramer was bullish on PDL BioPharma (PDLI), United Online (UNTD) and Vertex Pharmaceuticals (VRTX).

Lightning Round

Cramer was bullish on Amgen (AMGN), GOL Linhas Areas Inteligentes (GOL), Bank of America (BAC), Jones Soda (JSDA), American International Group (AIG), Flowserve (FLS), Rigel Pharmaceuticals (RIGL), Nastech Pharmaceutical (NSTK), Cemex (CX), Homex Development (HXM) and Lundin Mining (LMC).

Cramer was bearish on First Marblehead (FMD), Optium (OPTM) and Peabody Energy (BTU).

For more of Cramer's insights during the Lightning Round, click here.

---

Want more Cramer? Check out Jim's rules and commandments for investing from his popular book by clicking here.

>To order reprints of this article, click here: Reprints